{
    "output": [
        [
            "Bronstein, Gewirtz & Grossman, LLC",
            "ORG",
            "Represent",
            "Investors",
            "PERSON"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Involved_In",
            "Class_Action_Lawsuit",
            "EVENT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Submit",
            "NDA",
            "FIN_INSTRUMENT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Develop",
            "Pulmonary_Drug_Delivery_Systems",
            "PRODUCT"
        ],
        [
            "U.S. Food and Drug Administration",
            "ORG/GOV",
            "Discuss",
            "Linhaliq",
            "PRODUCT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Have",
            "Phase_III_Clinical_Trials",
            "EVENT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Make",
            "Materially_False_and_Misleading_Statements",
            "CONCEPT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Fail_to_Disclose",
            "Material_Information",
            "CONCEPT"
        ],
        [
            "FDA",
            "ORG/GOV",
            "Recommend",
            "Two_Adequate_and_Well-Controlled_Clinical_Trials",
            "EVENT"
        ],
        [
            "Aradigm Corporation",
            "COMP",
            "Drop",
            "Stock_Price",
            "FIN_INSTRUMENT"
        ],
        [
            "Investors",
            "PERSON",
            "Join",
            "Class_Action",
            "EVENT"
        ],
        [
            "Bronstein, Gewirtz & Grossman, LLC",
            "ORG",
            "Encourage",
            "Investors",
            "PERSON"
        ]
    ]
}